{{Rsnum
|rsid=2252586
|Chromosome=7
|position=54911231
|Orientation=plus
|GMAF=0.2089
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 40.2 | 52.7
| HCB | 0.0 | 4.4 | 95.6
| JPT | 0.0 | 1.8 | 98.2
| YRI | 9.5 | 38.8 | 51.7
| ASW | 7.0 | 49.1 | 43.9
| CHB | 0.0 | 4.4 | 95.6
| CHD | 0.9 | 8.3 | 90.8
| GIH | 4.0 | 17.8 | 78.2
| LWK | 16.5 | 40.4 | 43.1
| MEX | 5.2 | 36.2 | 58.6
| MKK | 9.6 | 45.5 | 44.9
| TSI | 14.7 | 28.4 | 56.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21531791
|Trait=None
|Title=Chromosome 7p11.2 (EGFR) variation influences glioma risk.
|RiskAllele=T
|Pval=8E-8
|OR=1.1800
|ORtxt=[1.11-1.25]
|OA=1
}}

Associated with [[glioma]] risk.

{{PMID|21825990}} Genetic causes of glioma: new leads in the labyrinth.

{{PMID Auto
|PMID=23161787
|Title=Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}